Cita APA

Li, J., Chiu, K., Wang, S., Yang, C., Chen, C., Ho, H., . . . Ou, Y. (2017). Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel. Front Pharmacol.

Citación estilo Chicago

Li, Jian-Ri, et al. "Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients After Docetaxel." Front Pharmacol 2017.

Cita MLA

Li, Jian-Ri, et al. "Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients After Docetaxel." Front Pharmacol 2017.